Unit of Muscular and Neurodegenerative Disorders, Laboratory of Molecular Medicine, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Pasteur Institute Italy - Cenci Bolognetti Foundation, Italy; Department of Biology and Biotechnologies "Charles Darwin", Sapienza University of Rome, Rome, Italy.
Biochim Biophys Acta Mol Basis Dis. 2017 Apr;1863(4):961-967. doi: 10.1016/j.bbadis.2017.01.022. Epub 2017 Jan 26.
The mitochondrial Elongation Factor Tu (EF-Tu), encoded by the TUFM gene, is a highly conserved GTPase, which is part of the mitochondrial protein translation machinery. In its activated form it delivers the aminoacyl-tRNAs to the A site of the mitochondrial ribosome. We report here on a baby girl with severe infantile macrocystic leukodystrophy with micropolygyria and a combined defect of complexes I and IV in muscle biopsy, caused by a novel mutation identified in TUFM. Using human mutant cells and the yeast model, we demonstrate the pathological role of the novel variant. Moreover, results of a molecular modeling study suggest that the mutant is inactive in mitochondrial polypeptide chain elongation, probably as a consequence of its reduced ability to bind mitochondrial aa-tRNAs. Four patients have so far been described with mutations in TUFM, and, following the first description of the disease in a single patient, we describe similar clinical and neuroradiological features in an additional patient.
线粒体延伸因子 Tu(EF-Tu)由 TUFM 基因编码,是一种高度保守的 GTP 酶,是线粒体蛋白翻译机制的一部分。在其激活形式下,它将氨酰-tRNA 递送到线粒体核糖体的 A 位。我们在这里报告了一名患有严重婴儿期巨囊性脑白质营养不良伴微脑回畸形和肌肉活检中复合物 I 和 IV 联合缺陷的女婴,其病因是 TUFM 中发现的一种新突变。使用人类突变细胞和酵母模型,我们证明了新型变体的病理性作用。此外,分子建模研究的结果表明,突变体在线粒体多肽链延伸中无活性,可能是由于其结合线粒体 aa-tRNA 的能力降低所致。迄今为止,已有四名患者被描述为 TUFM 突变,在首次描述单个患者的疾病后,我们在另一名患者中描述了类似的临床和神经影像学特征。